Cancer - Press Review (April 28, 2012) – Revue de presse (28 avril 2012)

Cancer – Press Review – Revue de Presse

Every week on
Chaque semaine sur

Press Review (April 28, 2012) – Revue de presse (28 avril 2012)

Healthy Behaviors Extend Life After Cancer, Experts Say
Eating well, exercising and maintaining normal weight boost survival,
American Cancer Society finds.
By Jenifer Goodwin. In U.S. News & World Report

Aspirin after bowel cancer diagnosis reduces chance of dying by 30 per
Taking aspirin after being diagnosed with bowel cancer can reduce the
chance of dying from the disease by 30 per cent, new research shows
In Cancer Research UK (press release)

FDA approves Glaxo cancer drug Votrient‎‎
U.S. regulators gave the nod to GlaxoSmithKline Plc's Votrient for a
type of sarcoma on Thursday, following a positive advisory panel vote
last month.
In Reuters.

FDA rejects Amgen's application for Xgeva
U.S. health regulators rejected the application by Amgen Inc, the
world's biggest biotechnology company, to expand the use of the drug
Xgeva to delay the spread of tumors to the bone in patients suffering
from advanced prostate cancer.
In Reuters.

Gene Critical to Development and Spread of Lung Cancer Identified‎
A single gene that promotes initial development of the most common
form of lung cancer and its lethal metastases has been identified by
researchers at Mayo Clinic in Florida. Their study suggests other
forms of cancer may also be driven by this gene, matrix
metalloproteinase-10 (MMP-10).
In Science Daily

Post-cancer fatigue “overestimated"
Despite widespread belief to the contrary, as few as 6% of women
experience cancer-related persistent fatigue a year after undergoing
treatment for breast cancer, a new study has found.
In ScienceAlert

Stanford Web tool helps patients weigh cancer risk
Four years ago, Raychel Kubby Adler opted to have a prophylactic
double mastectomy because of a genetic mutation that gave her an 87
percent lifetime chance of developing breast cancer. Now, the mother
of two daughters and a wellness coach in Davis is considering having
her ovaries removed.
By Victoria Colliver. In San Francisco Chronicle

Fewer Complications, Better Outcomes With Robot-Assisted Prostate
Cancer Surgery‎
Robot-assisted surgery is now both more common and far more successful
than radical "open" surgery to treat prostate cancer in the United
States, according to a new Henry Ford Hospital study published in the
current issue of the medical journal European Urology.
In Science Daily

Cancer: Choosing Quality of Life Over Aggressive Treatment
Amy Berman was diagnosed with terminal inflammatory breast cancer 18
months ago. To preserve her quality of life, Berman decided against
aggressive treatment of her disease in favor of palliative care.
By Amy Berman. In Washington Post

Anxiety increases cancer severity in mice, study shows‎
Worrywarts, fidgety folk and the naturally nervy may have a real cause
for concern: accelerated cancer. In a new study led by researchers at
the Stanford University School of Medicine, anxiety-prone mice
developed more severe cancer then their calm counterparts.
In Science Daily

Pourquoi les hommes ont plus de cancers que les femmes‎
Les hommes sont les premières victimes des cancers. Et comme le montre
une récente étude, le constat s'applique à tous les types de cancers.
Seules exceptions : ceux qui touchent les organes génitaux (utérus...)
et la thyroïde.
Par Didier Raoult. Dans Le Point

Cancer de la prostate L'espoir des ultrasons‎
Des résultats prometteurs ont été obtenus en Grande-Bretagne sur 41
patients présentant une petite tumeur localisée.
Sur El Watan

Des images 3D des tissus pour repérer et traiter le cancer‎
Un dépistage plus précoce du cancer serait possible grâce à une
nouvelle technique d’imagerie en 3D. Dans leur publication du American
Journal of Pathology, ils décrivent leur méthode de microscopie
Dans Maxi-Sciences

Cancer du sein : pas une, mais dix maladies différentes‎
Identifiées par des chercheurs de Cambridge, ces formes nécessitent
chacune un traitement particulier.
Par Damien Mascret. Dans Le Figaro

Cancer de la prostate: le dépistage sanguin sans intérêt‎
Nouvel élément d’importance dans la controverse sur les modalités
pratiques du dépistage du cancer de la prostate: le dépistage régulier
(par voie sanguine) ne présente pas de véritable intérêt, et ce y
compris chez les hommes considérés comme étant «à haut risque» pour
cette lésion maligne.

Cancer Blog – Marc Lacroix – Le Blogue du Cancer

Marc Lacroix-Corman – InTextoResearch – Baelen (04/2012)